Update: Botulinum Neurotoxin for the Treatment of Blepharospasm, Cervical Dystonia, Adult Spasticity, and Headache
Practice Guideline, April 2016
Read Published ArticleIn 2008, the American Academy of Neurology (AAN) published guidelines on the uses of botulinum neurotoxin (BoNT). New research on 4 indications—blepharospasm, cervical dystonia (CD), spasticity, and headache—prompted this update.
Reaffirmed on April 30, 2022.
Endorsed by the American Association of Neuromuscular & Electrodiagnostic Medicine and the American Society of Plastic Surgeons.
Clinician Tools and Materials
Clinician Summary
Download a PDF summary of this guideline product
Companion Publication - Botulinum Neurotoxin - Policy Perspectives
Download a companion piece to this guideline productCompanion Publication - Botulinum Neurotoxin - Gaps in Knowledge
Download a companion piece to this guideline productEducational Materials
Other resources related to this guideline
Patient Tools and Materials
Patient Summary
Read a summary of the key messages of this guideline product for patients and care partners.
Press Release
Download the AAN press release about this guideline product